X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1508) 1508
Publication (123) 123
Book Review (35) 35
Book Chapter (26) 26
Magazine Article (22) 22
Newsletter (9) 9
Conference Proceeding (5) 5
Dissertation (5) 5
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
acetyl-l-carnitine (1516) 1516
animals (741) 741
index medicus (596) 596
humans (572) 572
male (476) 476
rats (428) 428
neurosciences (380) 380
oxidative stress (366) 366
pharmacology & pharmacy (245) 245
l-carnitine (241) 241
acetylcarnitine - pharmacology (236) 236
female (227) 227
carnitine (202) 202
biochemistry & molecular biology (201) 201
brain (194) 194
levocarnitine (194) 194
metabolism (187) 187
mitochondria (187) 187
alpha-lipoic acid (173) 173
aging (151) 151
double-blind (147) 147
alzheimers-disease (142) 142
antioxidants (136) 136
rats, wistar (133) 133
carnitine - pharmacology (132) 132
mice (129) 129
acetylcarnitine - therapeutic use (123) 123
rats, sprague-dawley (123) 123
apoptosis (120) 120
analysis (116) 116
physiological aspects (114) 114
clinical neurology (112) 112
mitochondria - metabolism (112) 112
cell biology (109) 109
alzheimer's disease (106) 106
brain - metabolism (102) 102
dietary supplements (101) 101
health aspects (100) 100
adult (97) 97
disease models, animal (97) 97
research (97) 97
neurology (96) 96
middle aged (94) 94
mitochondria - drug effects (92) 92
chemotherapy (91) 91
oxidative stress - drug effects (88) 88
neurons (86) 86
rat (86) 86
article (81) 81
neuroprotection (80) 80
aged (79) 79
neurotoxicity (79) 79
cancer (78) 78
care and treatment (77) 77
old rats (77) 77
endocrinology & metabolism (76) 76
lipid-peroxidation (76) 76
mitochondrial dna (75) 75
antioxidants - pharmacology (73) 73
oncology (73) 73
placebo-controlled trial (73) 73
l-acetylcarnitine (72) 72
acetyl- l-carnitine (69) 69
neuropathy (69) 69
rat-brain (68) 68
time factors (66) 66
propionyl-l-carnitine (65) 65
psychiatry (64) 64
dose-response relationship, drug (63) 63
geriatrics & gerontology (63) 63
multidisciplinary sciences (63) 63
lipoic acid (62) 62
neuroprotective agents - pharmacology (62) 62
brain - drug effects (61) 61
nutrition & dietetics (61) 61
acetylcarnitine (60) 60
carnitine - analogs & derivatives (60) 60
carnitine - therapeutic use (60) 60
fatty acids (60) 60
pain (60) 60
peripheral neuropathy (60) 60
diabetes (59) 59
rodents (59) 59
energy metabolism (58) 58
medicine, research & experimental (58) 58
prevention (58) 58
acetylcarnitine - administration & dosage (56) 56
carnitine - metabolism (56) 56
drug therapy (56) 56
acetyl‐l‐carnitine (54) 54
biomedicine (54) 54
free radicals (54) 54
aging - physiology (53) 53
nerve growth-factor (53) 53
reactive oxygen species (53) 53
aging - metabolism (52) 52
biochemistry, general (52) 52
enzymes (52) 52
hippocampus (52) 52
mitochondrial dysfunction (52) 52
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1536) 1536
German (9) 9
Japanese (7) 7
Russian (5) 5
Chinese (3) 3
Spanish (3) 3
Polish (2) 2
Czech (1) 1
Hungarian (1) 1
Persian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Pharmacology, ISSN 0014-2999, 2011, Volume 650, Issue 1, pp. 335 - 341
Journal Article
Neuroscience Letters, ISSN 0304-3940, 06/2019, Volume 703, pp. 86 - 95
•First instance of ALC preventing glial activation in MPTP animals.•First instance of ALC preventing Glut-1, OCL, and ZO-1 loss in MPTP animals.•ALC preventing... 
Endothelial dysfunction | Neuroprotection | Parkinson’s disease | Acetyl-l-carnitine | Microglial activation
Journal Article
Molecular Neurobiology, ISSN 0893-7648, 9/2016, Volume 53, Issue 7, pp. 4286 - 4301
Oxidative stress and neuroinflammation are known causative factors in progressive degeneration of dopaminergic (DAergic) neurons in Parkinson’s disease (PD).... 
Neurology | Oxidative stress | Neuroprotection | Neurosciences | Biomedicine | Neuroblasts | Neurobiology | Acetyl- l -carnitine (ALCAR) | Neural stem cells | Wnt/ β -catenin pathway | Cell Biology | Acetyl-l-carnitine (ALCAR) | Wnt/β-catenin pathway | ACETYL-L-CARNITINE | Wnt/beta-catenin pathway | ALPHA-LIPOIC ACID | DOPAMINERGIC-NEURONS | SUBVENTRICULAR ZONE | SUBSTANTIA-NIGRA | NEUROSCIENCES | MGLU2 RECEPTORS | NEURAL STEM-CELLS | MOUSE MODEL | Acetyl-L-carnitine (ALCAR) | HIPPOCAMPAL NEUROGENESIS | CORPUS STRIATUM | Neuroprotective Agents - therapeutic use | Reactive Oxygen Species - metabolism | Acetylcarnitine - pharmacology | Dopaminergic Neurons - pathology | Neuroglia - pathology | Antioxidants - metabolism | Nitrites - metabolism | Male | Parkinson Disease - drug therapy | Oxidopamine | Neuroglia - drug effects | Behavior, Animal | Brain - metabolism | Cell Nucleus - metabolism | Neuroprotective Agents - pharmacology | Dopaminergic Neurons - metabolism | Lipid Peroxidation - drug effects | Ataxia - drug therapy | Dopaminergic Neurons - drug effects | Neurogenesis - drug effects | Parkinson Disease - metabolism | Phosphorylation - drug effects | Disease Models, Animal | Parkinson Disease - complications | Parkinson Disease - pathology | Neural Stem Cells - drug effects | Axons - drug effects | Axons - metabolism | Glycogen Synthase Kinase 3 beta - metabolism | Rats, Sprague-Dawley | Brain - drug effects | Phenotype | Animals | Wnt Signaling Pathway - drug effects | Axons - pathology | Brain - pathology | Neuroglia - metabolism | Ataxia - complications | Acetylcarnitine - therapeutic use | Oxidative Stress - drug effects | Cell Nucleus - drug effects | Neural Stem Cells - metabolism
Journal Article
Molecular and Cellular Biochemistry, ISSN 0300-8177, 12/2015, Volume 410, Issue 1, pp. 281 - 292
3-Nitropropionic acid (3-NP) is an irreversible inhibitor of succinate dehydrogenase and induces neuropathological changes similar to those observed in... 
Life Sciences | Biochemistry, general | Mitochondria | Lipid composition | 3-Nitropropionic acid | Alpha-lipoic acid | Medical Biochemistry | Oncology | Huntington’s disease | Cardiology | Acetyl- l -carnitine | Acetyl-l-carnitine
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 12, p. e14433
Background: Significant pain from HIV-associated sensory neuropathy (HIV-SN) affects similar to 40% of HIV infected individuals treated with antiretroviral... 
ANTIRETROVIRAL TOXIC NEUROPATHY | ACETYL-L-CARNITINE | CONCENTRATION CAPSAICIN PATCH | MULTIDISCIPLINARY SCIENCES | CLINICAL-TRIALS | DOUBLE-BLIND | PERIPHERAL NEUROPATHY | INFECTED PATIENTS | PLACEBO-CONTROLLED TRIAL | NATURAL-HISTORY | NERVE GROWTH-FACTOR | Peripheral Nervous System Diseases - etiology | Analgesics - therapeutic use | Capsaicin - therapeutic use | Humans | Anti-Retroviral Agents - pharmacology | Risk | Treatment Outcome | Nerve Growth Factor - therapeutic use | Randomized Controlled Trials as Topic | Cannabis | HIV Infections - complications | Placebos | HIV Infections - drug therapy | Peripheral Nervous System Diseases - complications | Plant Extracts - therapeutic use | Research Design | Peripheral Nervous System Diseases - drug therapy | Highly active antiretroviral therapy | Antiviral agents | Care and treatment | Pain | Analysis | Strategic planning (Business) | Levocarnitine | Nerve growth factor | Marijuana | HIV (Viruses) | Drug therapy | Therapy | Intensive care | Disease | Gabapentin | Capsaicin | Clinical trials | Systematic review | Infections | Criteria | Neuropathy | Peripheral neuropathy | Randomization | Analgesics | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Pain management | L-Carnitine | Recombinant | Antiretroviral drugs | Amitriptyline | Data analysis | Arbitration | Statistical analysis | Effectiveness | Acetyl-L-carnitine | Data processing | Pharmacology | College campuses | Antiretroviral therapy | Carnitine | Hospitals | Reviews | Acupuncture | Quality assessment | Lamotrigine | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
NATURE REVIEWS NEUROLOGY, ISSN 1759-4758, 11/2017, Volume 13, Issue 11, pp. 662 - 675
Fatigue, best described as an overwhelming feeling of tiredness and exhaustion, occurs in the context of various neurological diseases. The high prevalence of... 
COGNITIVE FUNCTIONS | MULTIPLE-SCLEROSIS PATIENTS | ACETYL-L-CARNITINE | SLEEP DISORDERS | POSTSTROKE FATIGUE | DOUBLE-BLIND | QUALITY-OF-LIFE | RANDOMIZED CONTROLLED-TRIAL | PITUITARY-ADRENAL AXIS | CLINICAL NEUROLOGY | PARKINSONS-DISEASE
Journal Article
Neurochemical Research, ISSN 0364-3190, 10/2019, Volume 44, Issue 10, pp. 2405 - 2412
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 01/2020, Volume 112, Issue 1, pp. 3 - 4
Journal Article
Journal of Internal Medicine, ISSN 0954-6820, 03/2014, Volume 275, Issue 3, pp. 251 - 283
Journal Article